Aktiespot

Pro Medicus Limited (PROMEDICUS FPO [PME]) Aktie

PME.AX

Geschlossen
$144.46+12.20 (+9.22%)
Chart wird geladen...

PROMEDICUS FPO [PME]

Eröffnung140.78
Hoch148.88
Tief139.13
Volumen340.06k
P/E64.49
Marktkapitalisierung15.09B
52-Wochen-Hoch336.00
52-Wochen-Tief107.75
Durchschn. Volumen354.65k
Dividende0.44%
Beta0.59
EPS2.24

Über Pro Medicus Limited (PROMEDICUS FPO [PME]) Aktie

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease, a mobile application that provides users access to medical imaging results; and Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Unternehmensinformationen

Börse: ASX (ASX)
Sektor: Sundhed
Branche: Sundhedsinformationstjenester
Adresse:
450 Swan Street
3121 Richmond, Australia
Telefon: + 61 3 9429 8800

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Anbefaling:1.73 - Køb
Niedrigstes Kursziel
54.00
62.6%
Durchschnittliches Kursziel
182.17
26.1%
Median Kursziel
200.00
38.4%
Höchstes Kursziel
245.00
69.6%

Andere sehen auch: